"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to KURA. [ FAQ on what and how to ask] For non-KURA questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Dr. Troy Edward Wilson J.D., Ph.D.
Headquarter: 4930 Directors Place, Suite 500, San Diego, CA, United States, 92121
Industry: Biotechnology, Investment Track: -, Employees: 260
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
My Watchlist
